Skip to main content
Right Decision Service: supporting decisions for Scotland's health and care
Scottish Palliative Care Guideleines
Scottish Palliative Care Guideleines
Menu
Pain
People with substance use disorder
Neuropathic pain
Pain assessment
Pain assessment - cognitive impairment
Pain management
Pain medicines / analgesics
Symptom management
Alternatives to regular medication normally given via a syringe pump or subcutaneous route when this is not available
Anorexia/cachexia
Bowel obstruction
Breathlessness
Constipation
Cough
Delirium
Depression
Diarrhoea
Hiccups
Hypercalcaemia
Lymphoedema
Mouth care
Nausea and vomiting
Pregnancy and breastfeeding
Pruritis
Seizures
Sweating
Weakness/fatigue
Palliative emergencies
Acute convulsive seizures
Allergic reaction to opioid
Bleeding
Catastrophic bleeding (haemoptysis, haematemesis, carotid artery erosion)
Haematemesis
Haemoptysis
Hypercalcaemia
Malignant spinal cord compression
Raised intracranial pressure (ICP)
Seizures
Stridor
Superior vena cava obstruction
Terminal agitation (also known as terminal restlessness or terminal delirium)
Medicines information
Choosing and changing opioids / opiates (converting/switching)
Alfentanil
Buccal midazolam
Buprenorphine patches
Clonazepam
Dexamethasone
Fentanyl buccal (Effentora)
Fentanyl nasal spray (PecFent)
Fentanyl patches
Fentanyl sublingual (Abstral)
Hydromorphone
Ketamine
Levetiracetam (subcutaneous infusion)
Levomepromazine
Lidocaine plaster
Methadone
Methylnaltrexone
Midazolam in palliative care
Morphine
Naloxone
Octreotide
Oxycodone
Phenobarbital (phenobarbitone)
Pregnancy and breastfeeding
Anticipatory prescribing
Syringe pump / driver guidelines
Syringe pump /driver guideline
Syringe pump / driver compatibles
Syringe pump /driver practice points
SOP template for using a syringe pump / driver in palliative care
Syringe pump /driver patient information
References & resources
Appendices
Last days of life
Care in the last days of life
Care of people with diabetes in the last days of life
End stage liver disease
Mouth care
Rapid transfer home in the last days of life
Renal disease in the last days of life
Severe uncontrolled distress
Subcutaneous fluids
Out of hours handover
Health and social care resources
Accessing the Palliative Care Formulary - video and guide
Compatibility and stability tables for subcutaneous infusion
Good practice guides
Palliative Care bulletins
Useful links for health and social care staff
Patient information leaflets
Alfentanil 5 mg/5 ml sublingual spray - patient information leaflet
Atropine sulfate 1% w/v eye drops used in the mouth for excess saliva - patient information leaflet
Buccal midazolam for seizures - patient information leaflet
Hyoscine Hydrobromide (Scopoderm) patient information leaflet
Ipratropium bromide for excess saliva - patient information leaflet
Ketamine for nerve pain - patient information leaflet
Levomepromazine for nausea, vomiting, agitation, delirium - patient information leaflet
Lorazepam under the tongue - patient information leaflet
Morphine (Zomorph®) taken via enteral feeding tubes - patient information leaflet
Olanzapine to treat nausea and vomiting - patient information leaflet
Rectal diazepam for seizures - patient information leaflet
Risperidone orodispersible tablets to treat agitation and delirium - patient information leaflet
Syringe pump information - patient information leaflet
Glycopyrronium to reduce saliva production
Opioids for breathlessness
About this toolkit
Contact us
Background
Methodology
Pharmacological considerations
Patient and family focus
Steering group membership
Guideline schedule
Accessibility
Scottish palliative care guidelines
Scottish palliative care guidelines-SEPARATEHOME
Back
Patient information leaflets
Atropine sulfate 1% w/v eye drops used in the mouth for excess saliva PDF
Navigation
Patient information leaflets
Alfentanil 5 mg/5 ml sublingual spray PDF
Alfentanil 5 mg/5 ml sublingual spray - patient information leaflet
Atropine sulfate 1% w/v eye drops used in the mouth for excess saliva PDF
Atropine sulfate 1% w/v eye drops used in the mouth for excess saliva - patient information leaflet
Buccal midazolam for seizures PDF
Buccal midazolam for seizures - patient information leaflet
Hyoscine hydrobromide patch for respiratory secretions and excess saliva (Scopoderm®) PDF
Hyoscine Hydrobromide (Scopoderm) patient information leaflet
Ipratropium bromide - patient information leaflet PDF
Ipratropium bromide for excess saliva - patient information leaflet
Ketamine for nerve pain PDF
Ketamine for nerve pain - patient information leaflet
Levomepromazine for nausea, vomiting, agitation and delirium PDF
Levomepromazine for nausea, vomiting, agitation, delirium - patient information leaflet
Lorazepam under the tongue PDF
Lorazepam under the tongue - patient information leaflet
Morphine (Zomorph®) taken via enteral feeding tubes PDF
Morphine (Zomorph®) taken via enteral feeding tubes - patient information leaflet
Olanzapine to treat nausea and vomiting PDF
Olanzapine to treat nausea and vomiting - patient information leaflet
Rectal diazepam for seizures PDF
Rectal diazepam for seizures - patient information leaflet
Risperidone orodispersible tablets to treat agitation and delirium PDF
Risperidone orodispersible tablets to treat agitation and delirium - patient information leaflet
Syringe pump - patient information leaflet PDF
Syringe pump information - patient information leaflet
Hyoscine Hydrobromide (Scopoderm) PIL 2024
Glycopyrronium to reduce saliva production
Glycopyrronium patient information leaflet
Opioids for breathlessness (do not publish)
Opioids for breathlessness
Print this page
Atropine sulfate 1% w/v eye drops used in the mouth for excess saliva PDF
Scottish palliative care guidelines-SEPARATEHOME
Resources
Use the button below to access this item.
Access this resource
Back to the top
Scottish palliative care guidelines-SEPARATEHOME
